Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

KETAMORE: TARGETING TREATMENT-RESISTANT OUD WITH KETAMINE-ASSISTED MINDFULNESS-ORIENTED RECOVERY ENHANCEMENT

NCT07369089 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT07369089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07369089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
KETAMORE: TARGETING TREATMENT-RESISTANT OUD WITH KETAMINE-ASSISTED MINDFULNESS-ORIENTED RECOVERY ENHANCEMENT
Lead sponsor
University of California, San Diego
Phase
Phase 2
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
April 30, 2028
Enrollment
88 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder